PRME Competitors & Alternatives

Compare Prime Medicine, Inc. Common Stock with similar stocks in the same industry

Biotechnology

PRME

Main Stock
$2.83
Tradestie Score
59
Market Cap
$996.55M
Revenue Growth
-0.4%
Analyst Upside
+151.9%

Top Competitors

230 stocks in Biotechnology
Company Price Market Cap P/E Score Action
KALV KalVista Pharmaceuticals, Inc. Common Stock
$27.00
$608.81M - 57 Compare
CTMX CytomX Therapeutics, Inc.
$3.15
$552.46M - 49 Compare
VSTM Verastem, Inc.
$5.76
$541.60M - 53 Compare
CRVS Corvus Pharmaceuticals, Inc.
$13.34
$540.97M - 50 Compare
ZVRA Zevra Therapeutics, Inc. Common Stock
$9.96
$529.35M 4.9 55 Compare
MNPR Monopar Therapeutics Inc. Common Stock
$113.97
$522.78M - 51 Compare
LXRX Lexicon Pharmaceuticals, Inc.
$2.32
$512.39M - 53 Compare
RIGL Rigel Pharmaceuticals Inc. (New)
$37.15
$505.12M 2.0 58 Compare
RGNX REGENXBIO Inc.
$9.98
$493.52M - 50 Compare
INBX Inhibrx Biosciences, Inc. Common Stock
$82.91
$492.21M - 50 Compare

Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)

230 stocks in this industry